HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.

AbstractOBJECTIVES:
The purpose of this study was to examine the prognostic value of midregional pro-atrial natriuretic peptide (MR-proANP) in patients with acute ischemic stroke.
BACKGROUND:
The rapid and reliable estimation of prognosis in acute ischemic stroke is pivotal to optimize clinical care. MR-proANP, a recently described, stable fragment of the ANP precursor hormone, may be useful in this setting.
METHODS:
In a prospective observational study, we measured MR-proANP on admission in plasma of 362 consecutive patients presenting with acute ischemic stroke. The prognostic value of MR-proANP to predict mortality within 90 days and functional outcome (defined as a modified Rankin Scale of ≤2 or ≥3) was evaluated and compared with the National Institutes of Health Stroke Scale (NIHSS) score.
RESULTS:
The discriminatory accuracy, calculated with the area under the curve (AUC) of the receiver operating characteristics curve, of MR-proANP to predict death was comparable to the NIHSS (AUC: 0.86 [95% confidence interval (CI): 0.82 to 0.90] and 0.85 [95% CI: 0.81 to 0.89; p = 0.7]). Combined, the accuracy significantly improved (0.92 [95% CI: 0.88 to 0.96; p < 0.01]). The AUC of MR-proANP to predict functional outcome was 0.70 (95% CI: 0.65 to 0.75), similar to the NIHSS (0.75 [95% CI: 0.70 to 0.80]; p = 0.16). The prognostic value of MR-proANP for both outcomes was independent of the NIHSS. Higher MR-proANP concentrations were found in stroke of cardioembolic etiology.
CONCLUSIONS:
MR-proANP is a prognostic marker in the acute phase of stroke, improving the discriminatory value of the NIHSS, independently predicting post-stroke mortality and functional outcome. (The "COSMOS"-Study [Copeptin in Osmoregulation and Stress Assessment]; NCT00390962).
AuthorsMira Katan, Felix Fluri, Philipp Schuetz, Nils G Morgenthaler, Christian Zweifel, Roland Bingisser, Ludwig Kappos, Andreas Steck, Stefan T Engelter, Beat Müller, Mirjam Christ-Crain
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 56 Issue 13 Pg. 1045-53 (Sep 21 2010) ISSN: 1558-3597 [Electronic] United States
PMID20846604 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Biomarkers
  • midregional pro-atrial natriuretic peptide, human
  • Atrial Natriuretic Factor
Topics
  • Aged
  • Aged, 80 and over
  • Atrial Natriuretic Factor (blood)
  • Biomarkers
  • Brain Ischemia
  • Female
  • Humans
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Stroke (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: